No trial has tested starting all four HFrEF drugs at once. What the speed evidence actually supports, where guidelines split, and how to close the implementation gap.
Nearly 80% of young adults are found to have risk factors for cardiovascular-kidney-metabolic syndrome, which is tied to poor ...
They entered medicine amid COVID, prior authorizations, corporate ownership, and collapsing public trust. Some mourn what ...
Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits ...
Across the globe, recreational ketamine use has been increasing, along with a spike in young adult patients presenting with ...
Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are ...
Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal ...
Higher nurse-led supportive care intensity is associated with a better quality of life and lower symptom burden in patients ...
Access to rheumatologists, medications, and nonpharmacologic care varies across Europe, with differences in specialist ...
A spoonful of unflavored gelatin mixed with warm water and consumed 15-30 minutes before a meal is being promoted on social ...
Cases of AI psychosis accumulate as we learn what happens when a very convincing computerized companion never disagrees with ...
Failure of an anti-inflammatory monoclonal antibody in the randomized trial shouldn’t be seen as negating the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results